” Our work is rooted in one simple yet profound belief that no one should suffer in silence. By combining science, compassion, and innovation, we are exploring the potentials of medical cannabis to save lives and improve the quality of lives for many.” – Mr. Bill Raffety
Establishing state-of-the-art Organic Medical Cannabis EU-GMP facilities worldwide. We assist in every phase of facility development, from strategic planning and design to operational setup, ensuring compliance with global standards for quality and safety.
Bridging the gap in supply shortages with top-tier products. By leveraging advanced cultivation techniques and scalable production capacities, we ensure a consistent supply of premium medical cannabis to underserved markets globally.
Bridging the gap in supply shortages with top-tier products. By leveraging advanced cultivation techniques and scalable production capacities, we ensure a consistent supply of premium medical cannabis to underserved markets globally.
Our cultivation practices adhere to Good Agricultural and Collection Practices (GACP), ensuring the highest quality standards in plant growth and harvesting. We optimise yields through cutting-edge technologies, sustainable farming methods, and a focus on genetic integrity.
We specialise in developing state-of-the-art cannabinoid extraction methodologies, utilising advanced
equipment and processes to produce pharmaceutical-grade extracts. This ensures purity, potency,
and safety in every product we develop.
MCC actively contributes to groundbreaking research, collaborating with renowned institutions and healthcare professionals. Our efforts include:
Identifying new therapeutic applications for cannabinoids.
Conducting Phase I-IV clinical trials to validate efficacy and safety.
Developing proprietary formulations tailored to specific medical conditions.
MCC actively contributes to groundbreaking research, collaborating with renowned institutions and healthcare professionals. Our efforts include:
Identifying new therapeutic applications for cannabinoids.
Conducting Phase I-IV clinical trials to validate efficacy and safety.
Developing proprietary formulations tailored to specific medical conditions.
